4th Brazilian Startup Day
Join us for the 4th edition of Brazilian Startup Day (Assembly Room on Loft on Two), a premier showcase of innovation and entrepreneurship in the life sciences sector, presented as part of the parallel programming of Brazilian Pharma & Health and Abiquifi during the BIO International Convention.
This high-impact morning event brings together a curated selection of Brazil’s most promising biotech and healthtech startups as they pitch cutting-edge solutions across therapeutics, diagnostics, biomanufacturing, and digital health. Brazilian Startup Day offers a unique opportunity for investors, corporates, and global stakeholders to discover breakthrough technologies and connect with the next generation of innovators shaping the future of health.
Whether you're seeking new partnerships, investment opportunities, or simply want to get a first look at emerging biotech talent from Brazil, this is an essential stop on your BIO 2025 agenda.
Agenda
8:30 - 9:00 AM - Doors Open / Check-In
9:00 - 9:10 AM - Opening Remarks
9:10 - 9:20 AM - Plug and Play Trend Report: Biotech in US
9:20 - 10:00 AM - Industry Panel Discussion & Q&A
10:00 - 11:10 AM - Startup Pitches
11:10 - 11:15 AM - Closing Remarks
11:20 - 12:30 PM - Speed Networking: Startups & Investors (Invite-only)
_____
🇧🇷 Featured Startups
Aptah Biosciences – Aptah Bio developed and patented the first-in-class RNA-based transcription modulation technology with a unique MoA. Our technology has already demonstrated preclinical proof-of-concept in oncology and neurodegenerative diseases, and we’re now preparing to move from the preclinical to the clinical stage, expand our pipeline, and accelerate development through strategic partnerships and investments.
Cellertz Bio – Cellertz developed and experimentally validated an AI-based platform for full-length mRNA design that increases mRNA stability, translation and therapeutic window. In its therapeutic program, Cellertz is exploring this platform to engineer T cells within the organism to treat cancer and autoimmune diseases.
Huna – Huna uses AI to analyze data from routine blood exams and detect early signs of cancer—turning everyday medical data into a low-cost, scalable triage solution for health systems worldwide.
ImunoTera – ImunoTera offers a unique biotechnological platform capable of restoring and activating immune system functions. The Act-Tera platform is based on a recombinant protein designed with high therapeutic precision to combat various types of cancer and infectious diseases.
Mirscience Therapeutics – Mirscience Tx is a biotech company developing oligonucleotide therapies that target the dark genome to treat age-related diseases. Our proprietary platform develops RNA therapies based on non-coding RNAs (miRNA, lncRNA, circRNA) that play key roles in disease development.
Peptidus – Peptidus Biotech is an AI Drug Discovery Platform for Peptide-Based Therapeutics in Animal Health, Delivering Results 3x Faster with 5x More Chances of Success.
Qnity – We leverage quantum electrochemistry to develop an extremely sensitive device for drug discovery and screening capable of analyzing multiple-sized molecules.
Sante Science – Sante Science is a foodtech/deeptech that has developed an innovative biotechnology through upcycling to produce natural ingredients that enhance treatment and reduce the symptoms of oncological chemotherapy in pets and humans, increasing quality of life, longevity, gastrointestinal and immunological health.
Science Biotech – Drug discovery and device development company, focused in out-license the pipeline under development, for several diseases.
Tissuelabs – The platform for creating tissues in the lab